Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon Jun Kim

Showing results (81-90 of 425) with videos related to

Pageof 43
Sort By:
Cancer Chemotherapy and Pharmacology|December 20, 2008
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinomaWon Kim, Jung-Hwan Yoon, Jung-Ryul Kim, et al.
BMC Cancer|October 16, 2020
CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinomaYoung Chang, Yun Bin Lee, Eun Ju Cho, et al.
Clinical and Molecular Hepatology|September 26, 2017
Current status and strategies for hepatitis B control in KoreaEun Ju Cho, Sung Eun Kim, Ki Tae Suk, et al.
Experimental & Molecular Medicine|January 5, 2007
Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearanceByung Lae Park, Yoon Jun Kim, Hyun Sub Cheong, et al.
Hepatology International|November 20, 2021
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patientsHye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, et al.
The Korean Journal of Hepatology|July 16, 2011
Treatment and clinical outcome of needle-track seeding from hepatocellular carcinomaDong-Won Ahn, Ju Hyun Shim, Jung-Hwan Yoon, et al.
Journal of Medical Virology|November 20, 2013
MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis BHwi Young Kim, Jung-Hwan Yoon, Hyo-Suk Lee, et al.
Human Mutation|February 13, 2004
Identification of variants in NFKBIA and association analysis with hepatocellular carcinoma risk among chronic HBV patientsLyoung Hyo Kim, Hyoung Doo Shin, Byung Lae Park, et al.
Journal of Medicinal Chemistry|April 23, 2021
Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV AgentsWooChan Kim, Jung-Ah Kang, Minji Park, et al.
Biochemical and Biophysical Research Communications|June 6, 2006
IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinomaYoon Jun Kim, Jung-Hwan Yoon, Chung Yong Kim, et al.
Pageof 43

Showing results (81-90 of 425) with videos related to

Sort By:
Pageof 43
Cancer Chemotherapy and Pharmacology|December 20, 2008
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinomaWon Kim, Jung-Hwan Yoon, Jung-Ryul Kim, et al.
BMC Cancer|October 16, 2020
CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinomaYoung Chang, Yun Bin Lee, Eun Ju Cho, et al.
Clinical and Molecular Hepatology|September 26, 2017
Current status and strategies for hepatitis B control in KoreaEun Ju Cho, Sung Eun Kim, Ki Tae Suk, et al.
Experimental & Molecular Medicine|January 5, 2007
Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearanceByung Lae Park, Yoon Jun Kim, Hyun Sub Cheong, et al.
Hepatology International|November 20, 2021
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patientsHye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, et al.
The Korean Journal of Hepatology|July 16, 2011
Treatment and clinical outcome of needle-track seeding from hepatocellular carcinomaDong-Won Ahn, Ju Hyun Shim, Jung-Hwan Yoon, et al.
Journal of Medical Virology|November 20, 2013
MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis BHwi Young Kim, Jung-Hwan Yoon, Hyo-Suk Lee, et al.
Human Mutation|February 13, 2004
Identification of variants in NFKBIA and association analysis with hepatocellular carcinoma risk among chronic HBV patientsLyoung Hyo Kim, Hyoung Doo Shin, Byung Lae Park, et al.
Journal of Medicinal Chemistry|April 23, 2021
Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV AgentsWooChan Kim, Jung-Ah Kang, Minji Park, et al.
Biochemical and Biophysical Research Communications|June 6, 2006
IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinomaYoon Jun Kim, Jung-Hwan Yoon, Chung Yong Kim, et al.
Pageof 43